Interpace Diagnostics

Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, is a leading provider of molecular testing for thyroid nodules. The Company offers ThyGeNEXT®  + ThyraMIR®v2, a unique combination testing platform that utilizes both mutational and microRNA markers to risk-stratify indeterminate thyroid nodules, helping to inform patient management decisions.